USANA HEALTH SCIENCES INC

USNA

Explore Our Financial Data > Companies > USANA HEALTH SCIENCES INC

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	USNA
CIK	0000896264
SIC	2833
Sector	Manufacturing
Industry Category	Pharmaceutical Products
Industry Group	Medicinal Chemicals

Contact

Address	3838 WEST PARKWAY BLVD., SALT LAKE CITY, UT, 84120-6336
Website	usana.com
Phone	8019547100
CEO	Kevin G. Guest
Employees	1,900

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$925.94 million
Pre-Tax Income	$40.25 million
Net Income	$9.15 million
Net Income to Common	$8.87 million
EPS	$0.50

View All

Balance Sheet

Cash	$162.75 million
Assets	$738.97 million
Liabilities	$144.18 million
Common Equity	$543.55 million
Liabilities & Equity	$738.97 million

View All

Cash Flow Statement

Net Income	$9.15 million
Cash From Operating Activities	$16.63 million
Cash From Investing Activities	$-8.85 million
Cash From Financing Activities	$-29.78 million
Change in Cash	$-16.71 million

View All

Calculations

NOPAT	$8.10 million
EBITDA	$71.30 million
Price to Earnings	$38.99
Price to Book	$0.64
ROE	1.55%

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

5 Revealing Analyst Questions From USANA’s Q1 Earnings Call

USANA’s first quarter saw steady performance, with revenue flat year-over-year and a positive market reaction following results that surpassed Wall Street expectations. Management credited sequential improvements in their core nutritional business to active customer growth, particularly in China, and highlighted the impact of new product launches and investments in technology modernization. CEO Kevin Guest emphasized, “Our first quarter results reflect USANA’s continued and deliberate transforma

Article Link

USNA or SDZNY: Which Is the Better Value Stock Right Now?

USNA vs. SDZNY: Which Stock Is the Better Value Option?

Article Link

USANA Health (USNA) Upgraded to Buy: What Does It Mean for the Stock?

USANA Health (USNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Article Link

Should Value Investors Buy USANA Health Sciences (USNA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Article Link

USANA Health Sciences, Inc. Just Recorded A 78% EPS Beat: Here's What Analysts Are Forecasting Next

As you might know, USANA Health Sciences, Inc. ( NYSE:USNA ) just kicked off its latest first-quarter results with some...

Article Link